Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,504 | -6,585 | -28,323 | -19,660 | -14,096 |
| Depreciation Amortization | 484 | 250 | 929 | 847 | 560 |
| Accounts receivable | 484 | 1,325 | -956 | -155 | -27 |
| Other Working Capital | 602 | 1,056 | 353 | 165 | 132 |
| Other Operating Activity | 1,186 | -575 | 5,388 | 3,523 | 2,489 |
| Operating Cash Flow | $-10,748 | $-4,529 | $-22,609 | $-15,280 | $-10,942 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,227 | -623 | -912 | -489 | -372 |
| Common Stock Issued | 22,939 | 22,938 | 2,668 | 2,664 | 2,662 |
| Other Financing Activity | -1,859 | -1,859 | 0 | -220 | -146 |
| Financing Cash Flow | $19,853 | $20,456 | $1,756 | $1,955 | $2,144 |
| Exchange Rate Effect | -1,239 | -960 | 549 | 433 | 1,556 |
| Beginning Cash Position | 26,213 | 26,213 | 46,517 | 46,517 | 46,517 |
| End Cash Position | 34,079 | 41,180 | 26,213 | 33,625 | 39,275 |
| Net Cash Flow | $7,866 | $14,967 | $-20,304 | $-12,892 | $-7,242 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,748 | -4,529 | -22,609 | -15,280 | -10,942 |
| Free Cash Flow | -10,748 | -4,529 | -22,609 | -15,280 | -10,942 |